IRVINE, Calif., March 21, 2013 (GLOBE NEWSWIRE) -- Sabra Health Care REIT, Inc. ("Sabra" or the "Company") (Nasdaq:SBRA) today announced the closing of an underwritten public offering of 5,750,000 shares of 7.125% Series A Cumulative Redeemable Preferred Stock (the "Series A Preferred Stock") at a price of $25.00 per share, pursuant to an effective registration statement, for net proceeds of approximately $138.2 million after deducting underwriting discounts and other estimated offering expenses. The 5,750,000 shares of the Company's Series A Preferred Stock includes the underwriters' exercise in full on March 20, 2013 of their option to purchase up to an additional 750,000 shares of the Company's Series A Preferred Stock. The Series A Preferred Stock is expected to be admitted for trading on the NASDAQ Global Select Market under the symbol "SBRA PA" within 30 days of the date of closing.
Sabra Announces Closing Of 7.125% Series A Cumulative Redeemable Preferred Stock
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.